1-19 of 19
Ann S. LaCasce, MD, MSc
Close
Sort by
Articles

The Evolution of Immunotherapy in Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7002
Published: 2017
Articles

Targeting PD-1 Classical Hodgkin Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2016) 13 (6)
https://doi.org/10.1182/hem.V13.6.6723
Published: 2016
Articles

Characterizing Pediatric-Type Nodal Follicular Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2016) 13 (5)
https://doi.org/10.1182/hem.V13.5.6536
Published: 2016
Articles

Understanding Immune Escape in Classical Hodgkin Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5627
Published: 2016
Articles

BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2016) 13 (3)
https://doi.org/10.1182/hem.V13.3.5479
Published: 2016
Articles

Novel Targets in Primary Central Nervous System Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2016) 13 (2)
https://doi.org/10.1182/hem.V13.2.5114
Published: 2016
Articles

Using Interim PET to Direct Therapy for Early Hodgkin Lymphoma: Results from the Trials

Peter Johnson, MD, Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2016) 13 (1)
https://doi.org/10.1182/hem.V13.1.4825
Published: 2016
Articles

M7FLIPI: A Follicular Lymphoma Prognostic Model for the 21st Century

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (6)
https://doi.org/10.1182/hem.V12.6.4482
Published: 2015
Articles

CAR T Cells in Refractory Diffuse Large B-cell Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (5)
https://doi.org/10.1182/hem.V12.5.4307
Published: 2015
Articles

Circulating Tumor Specific DNA: A Promising Biomarker in Diffuse Large B-cell Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (4)
https://doi.org/10.1182/hem.V12.4.4116
Published: 2015
Articles

Navigating Future Challenges in Lymphoma: A Map for the Road Ahead

David M. Weinstock, MD, Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (3)
https://doi.org/10.1182/hem.V12.3.4003
Published: 2015
Articles

PD-1 Inhibition and Hodgkin Lymphoma: A Perfect Therapeutic Match

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (2)
https://doi.org/10.1182/hem.V12.2.3697
Published: 2015
Articles

Targeted Therapy in Lymphoproliferative Disorders (Excluding CAR T Cells)

Peter Johnson, MD, Jason Gotlib, MD, MS, Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (1)
https://doi.org/10.1182/hem.V12.1.3626
Published: 2015
Articles

Targeting Bromodomain Proteins in DLBCL

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2014) 11 (6)
https://doi.org/10.1182/hem.V11.6.3304
Published: 2014
Articles

The Role of Brentuximab Vedotin in Previously Untreated Patients with CD30-Positive T-Cell Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2014) 11 (5)
https://doi.org/10.1182/hem.V11.5.3177
Published: 2014
Articles

NF-κB is Key in Mantle Cell Lymphoma

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2014) 11 (4)
https://doi.org/10.1182/hem.V11.4.2944
Published: 2014
Articles

Unlocking the Mysteries of AITL

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2014) 11 (3)
https://doi.org/10.1182/hem.V11.3.2744
Published: 2014
Articles

Latency No Longer a Haven for Epstein-Barr Virus

Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2014) 11 (2)
https://doi.org/10.1182/hem.V11.2.2565
Published: 2014
Articles

Optimal, Upfront Management of Mantle Cell Lymphoma

Oreofe O. Odejide, MD, Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2012) 9 (6)
https://doi.org/10.1182/hem.V9.6.1107
Published: 2012